Interim recommendations for heterologous COVID-19 vaccine schedules: interim guidance, 16 December 2021
|
This interim guidance pertains to heterologous primary and heterologous boosting schedules of Covid-19 vaccines. It focuses on heterologous schedules combining multiple vaccine platforms (e.g. a vectored vaccine followed by an mRNA vaccine). |